Πέμπτη 27 Ιουνίου 2019

Association of Methylenetetrahydrofolate Reductase, Vitamin D Receptor, and Interleukin-16 Gene Polymorphisms With Renal Cell Carcinoma Risk
Technology in Cancer Research &Treatment, Volume 18, Issue , January 2019. In this meta-analysis, we investigated the association of methylenetetrahydrofolate reductase, vitamin D receptor, and interleukin-16 gene polymorphisms with the risk of renal cell carcinoma. We searched the PubMed and Cochrane Library databases up to July 1, 2017, and included 12 eligible case–control studies in our analysis. The vitamin D receptor ApaI A allele, ApaI AA and aa genotypes, BsmI B allele, and Fok1 FF genotype...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
07:25
Goal-Driven Beam Setting Optimization for Whole-Breast Radiation Therapy
Technology in Cancer Research &Treatment, Volume 18, Issue , January 2019. Purpose:To develop an automated optimization program to generate optimal beam settings for whole-breast radiation therapy driven by clinically oriented goals.Materials and Methods:Forty patients were retrospectively included in this study. Each patient’s planning images, contoured structures of planning target volumes, organs-at-risk, and breast wires were used to optimize for patient-specific–beam settings. Two beam geometries...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
07:24
IL-9 Exerts Antitumor Effects in Colon Cancer and Transforms the Tumor Microenvironment In Vivo
Technology in Cancer Research &Treatment, Volume 18, Issue , January 2019. As a newly discovered cytokine, interleukin 9 was initially considered a T-lymphocyte growth factor. Interleukin 9 affects target cells by binding to a member of the γc-family of receptors and is involved in inflammation, autoimmune diseases, and other ailments. In recent years, mounting evidence reveals that interleukin 9 exerts antitumor effects, which has attracted considerable attention. Many previous studies were...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
07:23

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου